Cargando…
α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
α‐Synucleinopathies including idiopathic Parkinson's disease, dementia with Lewy bodies and multiple systems atrophy share overlapping symptoms and pathological hallmarks. Selective neurodegeneration and Lewy pathology are the main hallmarks of α‐synucleinopathies. Currently, there is no imagin...
Autores principales: | Alzghool, Obada M., van Dongen, Guus, van de Giessen, Elsmarieke, Schoonmade, Linda, Beaino, Wissam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310945/ https://www.ncbi.nlm.nih.gov/pubmed/35289424 http://dx.doi.org/10.1002/mds.28984 |
Ejemplares similares
-
A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide Vaccine
por: Yu, Hui Jing, et al.
Publicado: (2022) -
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
por: García‐Sanz, Patricia, et al.
Publicado: (2020) -
High‐Contrast Imaging of α‐Synuclein Pathologies in Living Patients with Multiple System Atrophy
por: Matsuoka, Kiwamu, et al.
Publicado: (2022) -
RT‐QuIC Detection of Pathological α‐Synuclein in Skin Punches of Patients with Lewy Body Disease
por: Mammana, Angela, et al.
Publicado: (2021) -
Validation of α‐Synuclein in L1CAM‐Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes
por: Jiang, Cheng, et al.
Publicado: (2021)